MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178

  • J Antibiot (Tokyo). 1993 Dec;46(12):1775-81. doi: 10.7164/antibiotics.46.1775.
S Nakanishi  1 K Ando I Kawamoto Y Matsuda
Affiliations
  • 1. Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan.
Abstract

MS-347a was isolated from the culture broths of Aspergillus sp. KY52178 as an inhibitor of smooth muscle Myosin light chain kinase (MLCK). MS-347a inhibited the activity of chicken gizzard MLCK with an IC50 value of 9.2 microM. The inhibition was dependent on time of preincubation of MS-347a with the enzyme, suggesting irreversible inhibition. It is likely that the inhibitor binds to the catalytic domain of MLCK, since the compound inhibited not only calmodulin-dependent but also calmodulin-independent activity of MLCK. Calmodulin-dependent cyclic nucleotide phosphodiesterase, cAMP-dependent protein kinase and cGMP-dependent protein kinase were not inhibited by 150 microM MS-347a at all, although the compound inhibited protein kinase C with an IC50 value of 16 microM. MS-347b, a minor component was also isolated from the same culture broths. This minor component at 150 microM did not inhibit the activity of MLCK.

Products